7 May 2024 - In this cohort study of cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did ...
29 April 2024 - Recommendation supported by results from the Phase 3 STREAM Stage 2 study, which show bedaquiline-containing regimens offer ...
29 April 2024 - Designation is based on data from the Phase 3 program for diazoxide choline. ...
29 April 2024 - The US FDA has approved Xolremdi (mavorixafor) capsules in patients 12 years of age and older with ...
29 April 2024 - Today, the FDA granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen) for recurrent or metastatic cervical ...
29 April 2024 - Recommendation based on CAPItello-291 results which showed the Truqap combination reduced the risk of disease progression ...
28 April 2024 - Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's ...
25 April 2024 - Biosimilar price will be about 85% lower than Humira. ...
29 April 2024 - The Government will boost PHARMAC’s budget by more than $1.7 billion over the next four years, ...
24 April 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
26 April 2024 - Breast Cancer Network Australia (BCNA) today welcomed a decision by the PBAC to recommend the life ...
28 April 2024 - Former Deputy Prime Minister Paula Bennett has been appointed the new chair of the national drug ...
26 April 2024 - The EMA’s CHMP recommended eight medicines for approval at its April 2024 meeting. ...
23 April 2024 - Gene editing and therapy to replace missing or defective genes is one of the most exciting ...
26 April 2024 - This week, the FDA approved the 50th biosimilar, reflecting the markedly increased availability of biosimilar products—products that ...
28 April 2024 - For the first time in 15 years women with an invasive form of early breast cancer ...